Stay updated on Pembrolizumab for Lung Cancer Prevention Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.

Latest updates to the Pembrolizumab for Lung Cancer Prevention Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays revision v3.6.5, replacing the previous v3.6.4, indicating a routine update to the study record display. This change does not affect the study content or user interaction.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a platform/software upgrade for the page. The change represents an internal version bump rather than a modification to study details or visible content.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, signaling a newer page revision. This reflects a minor maintenance update to the page or its templates rather than a substantive change to study details.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, signaling a new build or patch of the page. This update appears to be a maintenance/versioning change rather than a modification to the trial details or user-facing content.SummaryDifference0.1%

- Check66 days agoChange DetectedThe recruitment status was updated to indicate enrollment has closed ('No longer looking for participants'). The page also introduces or updates several help and navigation sections, standardizes the Intervention/Treatment heading, and updates the revision tag to v3.6.0.SummaryDifference0.4%

- Check74 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5. This appears to be a minor software update with no visible changes to study details or content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Lung Cancer Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.